Month: September 2025

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — New research from iStock, a leading ecommerce platform providing premium content to SMBs, SMEs, creatives, and students everywhere, reveals that climate change awareness is stronger than ever, and it’s directly influencing consumer behavior. Findings from iStock’s VisualGPS research platform reveal that 69% of people globally say they feel the effects of climate change in their daily lives, with heightened awareness shaping how people live. In fact, 73% of consumers say they make a conscious effort to avoid negatively impacting the planet, and 57% are actively working to reduce their carbon footprint. This mindset extends beyond lifestyle into purchasing decisions: 6 in 10 people globally say they will go out of their way to spend money with businesses whose values align with their own.Whether...

PETACH TIKVA, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that senior management will participate in the upcoming 27th Annual H.C. Wainwright Global Investment Conference taking place on September 8-9, 2025, at the Lotte New York Palace Hotel, New York City. PolyPid’s fireside chat with H.C. Wainwright Managing Director, Equity Research, Brandon Folkes, will take place from 11:30 AM – 12:00 PM ET on Monday, September 8, 2025. The PolyPid management team will participate in virtual and in-person one-on-one investor meetings during this event. Investors attending the event may request a one-on-one meeting with PolyPid through their H.C. Wainwright representative...

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — via InvestorWire — Solowin Holdings (NASDAQ: SWIN)today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, “Hong Kong Reinforces Regulated Crypto Bridge as Asian Institutional Demand Surges,” please visit: https://nnw.fm/UZeVJ. As Asia ascends to the forefront of the global crypto-finance landscape, Hong Kong is reclaiming its historical niche as a regulated gateway linking traditional finance with digital assets. Institutional appetites are visibly rising for compliant, algorithmically...

North Wales, PA, Sept. 03, 2025 (GLOBE NEWSWIRE) — Toppoint Holdings Inc. (NYSE American: TOPP) (“Toppoint” or the “Company”), a leading truckload services and logistics provider focused on the recycling export supply chain, today announced that its wholly owned subsidiary, Toppoint Inc, has added a significant new customer in the recycling sector. The new client, a multi-state recycling producer operating seven strategically located facilities across Massachusetts, New Jersey, and Connecticut, represents one of the largest independent recyclers in the Northeast region. This new customer relationship reinforces Toppoint’s longstanding pledge to support the recycling industry and aligns directly with the Company’s strategy of growing its role in the U.S. export market. By partnering with one of the region’s most prominent recycling...

Newest Bathroom Essential from the Creators of the #1 Way to #2 100% Plant-Based Fibers, Hypoallergenic, and Septic Safe SUMMIT, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) — Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced the launch of Squatty Potty Wipes, the Company’s flagship entry into the consumable products market. Squatty Potty wipes are now available for sale in the United States on Amazon.com and www.squattypotty.com. The wipes launched in the United Kingdom in late August 2025 are also available at Amazon.co.uk. Squatty Potty wipes are pH balanced, alcohol free, cruelty free (no animal testing), and safe for sensitive and eczema prone skin. Made with 100% plant-based fibers, Squatty Potty wipes leave you feeling fresh and clean, and are flushable and septic safe when flushed according to packaging...

Live moderated webcast on Thursday, September 4th at 4:00 PM ET Access the event here BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced that it will participate in the Virtual Investor Closing Bell Series on Thursday, September 4, 2025 at 4:00 PM ET. As part of the event, Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics will provide a corporate overview and discuss its innovative payload platform fueling a pipeline of next-generation ADCs designed with novel immuno-oncology payloads to address a wide range of cancer tumor targets. In addition to the moderated discussion, investors and interested parties will...

GLEN ALLEN, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC (“Nasdaq”) to regain compliance with the Nasdaq’s minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on Nasdaq (the “Minimum Bid Price Requirement”), following the expiration of the initial 180 calendar day period to regain compliance on September 1, 2025, which was initially granted on March 5, 2025. The Company now has until March 2, 2026 to meet the Minimum Bid Price Requirement set forth in Nasdaq...

New longer-term post hoc analysis results of responders (n=6)1 showed long-lasting, durable pain reduction of nearly 66%, or a mean 5.08 reduction on the VAS pain scale, in patients with severe pancreatic cancer pain 100% of responders (n=7) 1 showed zero opioid use at their 3-month post-procedure follow-up2 Quality of life markers further improved including sleep quality, energy level and ability to lead normal daily and leisure time activities and reduced tension, vomiting and constipation THE WOODLANDS, TX, Sept. 03, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced new longer-term post hoc data from its initial trial phase of its first-in-human study proof-of-concept evaluating the...

Peer-reviewed research proves that HydroGraph ultra-pure graphene offers cost-effective, reusable adsorption medium for wastewater purification VANCOUVER, British Columbia, Sept. 03, 2025 (GLOBE NEWSWIRE) — HydroGraph Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph”), a leading producer of ultra-pure graphene, today announced the publication of a peer-reviewed study that demonstrates the potential of using HydroGraph graphene as a scalable solution for industrial wastewater treatment. The study, published in FlatChem (Elsevier), confirms that HydroGraph’s graphene can remove 100% of six organic dyes from wastewater within 10 minutes. The global wastewater market is projected to reach $20.01 billion by 2025 and $28.95 billion by 2032 at a CAGR of 5.4%. Organic dyes are a major pollutant in local water sources, and wastewater is often...

Kennewick, WA, Sept. 03, 2025 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL) Vivos Inc filed a provisional patent No.: 63/873,014 – STERILE THERMOGELS Vivos Inc. is pleased to announce the successful validation of a new electron beam (E-Beam) sterilization process for our hydrogel, marking a culmination of nearly a year of testing and validation of a process that was only viable because of the unique characteristics of our hydrogel. The validation was carried out under ISO 11137 by an international medical device accredited organization. Vivos applies these same high standards to both human (Radiogel®) and animal (Isopet®) therapies. The E-Beam sterilization process is reproduceable and more reliable than our current filtration process, achieving a sterility assurance level of 10-6, which is the most rigorous sterility level;...